Sensoril® ashwagandha — a science-backed ingredient by Kerry Group — has been shown to support quality of life for women post menopause, according to a new clinical study. With the potential for women to spend up to 40 percent of their lives post-menopause, it is crucial that those years are enjoyable.1 This recently published study validates Sensoril's unique ability to support symptom management and quality of life in women post-menopause, at as low as 250mg/day. This research builds on … [Read more...] about Clinical study demonstrates Kerry Group supplement solution Sensoril® ashwagandha supports quality of life for post-menopausal women
clinical study
Sporevia probiotic can reduce staph colonization by more than 95%, study finds
Kerry Group’s probiotic strain Sporevia (Bacillus subtilis MB40) can eliminate Staphylococcus aureus in the human body by more than 95 percent, a clinical trial has found. Staphylococcus aureus (S. aureus), commonly known as “staph,” is a pathogen that caused over 119,000 infections and nearly 20,000 deaths in the US in 2017.1 However, the use of oral antibiotics for staph decolonization is advised against because of its effect on the gut microbiota and antibiotic resistance.2 Sporevia … [Read more...] about Sporevia probiotic can reduce staph colonization by more than 95%, study finds
